{"id":"W2809887875","doi":"10.1186/s12959-018-0176-2","title":"COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study","year":2018,"lang":"en","type":"article","venue":"Thrombosis Journal","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Janssen Pharmaceuticals; Janssen Scientific Affairs; Bayer","keywords":"Medicine; Rivaroxaban; Quality of life (healthcare); Venous thromboembolism; Cancer; Low molecular weight heparin; Intensive care medicine; Anticoagulant; Vitamin K antagonist; Thrombosis; Internal medicine; Warfarin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001841083,0.0006045319,0.0009726449,0.0006526763,0.000825254,0.001370056,0.0004821297,0.0009683951,0.003790374],"category_scores_gemma":[0.00289181,0.0004584903,0.002049868,0.001047059,0.0004517367,0.001056476,0.0006704445,0.001347322,0.001194309],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006440468,"about_ca_system_score_gemma":0.001193731,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001804329,"about_ca_topic_score_gemma":0.002004406,"domain_scores_codex":[0.9989164,0.0002917453,0.0001449359,0.0002611114,0.0002272334,0.000158611],"domain_scores_gemma":[0.997663,0.000297867,0.0007360561,0.0001392431,0.0004379743,0.0007258051],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06344479,0.02139586,0.8681934,0.001966269,0.004121789,0.0005120814,0.0007471329,0.0002423039,0.001090534,0.0005997067,0.006777681,0.03090838],"study_design_scores_gemma":[0.01644598,0.04599798,0.9217744,0.0003349289,0.002346559,0.001114145,0.0007623172,0.0004532768,0.000240914,0.0002747412,0.010178,0.00007682477],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9865577,0.00224905,0.0001838424,0.0003406161,0.0001570338,0.002231229,0.002973041,0.00001464883,0.005292929],"genre_scores_gemma":[0.9860517,0.001211029,0.0005526868,0.00113277,0.0006526159,0.002323122,0.006000481,0.000009677245,0.002065923],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003790374,"threshold_uncertainty_score":0.01268005,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03361475804794766,"score_gpt":0.3513641826824143,"score_spread":0.3177494246344666,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}